During Thursday’s Current trade, Shares of Greenbrier Companies Inc (NYSE:GBX), gain 3.81% to $36.26.
The Greenbrier Companies, Inc. (GBX) declared that it anticipates to exceed formerly offered diluted EPS guidance of $5.70 to $5.85 (not taking into account non-recurring costs in the third quarter of $0.16 per share) for the fiscal year ended August 31, 2015. These higher expectations are principally driven by raised margins in the Company’s manufacturing segment, which comprises lease syndications and a lower than anticipated tax rate related to geographic mix of earnings. In addition, Greenbrier revealed it received diversified new orders in its fourth quarter ended August 31, 2015 for 2,900 railcar units valued at $470 million. Orders for the quarter comprise medium and large cube covered hopper cars, automobile carrying cars, boxcars and tank cars. The tank car orders comprise a recent award for 1,200 tank cars from Saudi Railway Company (SAR). (More details on the SAR order can be found in a separate news release issued recently by the Company.)
The Greenbrier Companies, Inc. designs, manufactures, and markets railroad freight car equipment in North America and Europe.
Shares of Quest Diagnostics Inc (NYSE:DGX), declined -0.29% to $62.50, during its current trading session.
In advance of the 2015-2016 flu season, Focus Diagnostics, the products business of Quest Diagnostics (DGX), declared that its Simplexa™ Flu A/B & RSV Direct Kit has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for 46 additional influenza A and influenza B virus strains and 7 additional respiratory syncytial virus (RSV) strains.
The FDA granted 510(k) initial clearance to the Simplexa test kit for select virus strains in July 2012 and clearance of some additional strains in 2014. With the recent clearance, the Simplexa test can detect a total of 92 influenza and RSV virus strains, more than any other FDA-cleared molecular test kit. These comprise all four influenza strains the World Health Organization recommends be comprised of in vaccines during the northern hemisphere’s 2015-2016 influenza season: A/Switzerland/9715293/2013 (H3N2)-like virus; A/California/7/2009 (H1N1)-like virus, B/Phuket/3073/2013-like virus and B/Brisbane/60/2008-like virus.
In addition, the 46 new influenza strains comprise 20 avian influenza A and two swine influenza virus strains. These may be increasingly important to detect, as avian and swine influenza viruses can carry over into human populations.
Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, in addition to related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; analytic, on-site prevention, and wellness services; laboratory outreach services; and risk assessment services for the life insurance industry.
EQT Corporation (NYSE:EQT), during its Thursday’s current trading session gained 1.30% to $74.24.
EQT Midstream Partners, LP and EQT GP Holdings, LP will host a joint teleconference with security analysts on October 22, starting at 11:30 a.m. Eastern Time. Topics of the teleconference will comprise financial results, operational results, and other matters with respect to the third quarter of 2015. A brief Q&A session for security analysts will right away follow the results talk about. The teleconference will be webcast live at http://www.eqtmidstreampartners.com, with a replay accessible for seven days following the call.
EQT Corporation (EQT), which is the parent company of the two limited partnerships, will also host the third quarter earnings teleconference with security analysts on October 22, startning at 10:30 a.m. Eastern Time.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
